Medicare Doughnut Hole

(redirected from Medicare Part D Coverage Gap)
Also found in: Wikipedia.
Formally known as the Medicare Part D Coverage Gap. The difference between the initial coverage limit and the catastrophic coverage threshold, as described in the Medicare Part D prescription drug program. After a Medicare beneficiary surpasses the prescription drug coverage limit, the Medicare beneficiary is financially responsible for the entire cost of prescription drugs until the expense reaches the catastrophic coverage threshold, fancifully likened to a doughnut which provides pleasure to the consumer until he hits the centre—no joy—then returns to the happy part
References in periodicals archive ?
Effect of the Medicare Part D Coverage Gap on Medication Use among Patients with Hypertension and Hyperlipidemia.
Changes in Drug Utilization during a Gap in Insurance Cover age: An Examination of the Medicare Part D Coverage Gap.
WASHINGTON -- Starting next year, the nation's pharmaceutical manufacturers will provide 50% discounts on the cost of covered branded prescription drugs to beneficiaries in the Medicare Part D coverage gap, the so-called doughnut hole.
Require pharmaceutical manufacturers to offer a 50 percent discount on brand-name prescriptions filled in the Medicare Part D coverage gap beginning in 2011, and begin phasing in federal subsidies for generic prescriptions filled in the Medicare Part D coverage gap.
Begin phasing in federal subsidies for brand-name prescriptions filled in the Medicare Part D coverage gap.
New functionality for pharmaceutical manufacturers to help manage the requirements of the Medicare Part D coverage gap program and minimize risk
For pharmaceutical manufacturers, new quarterly requirements to close 50 percent of the Medicare Part D coverage gap discount have created the need for a simplified solution to effectively manage this rebate process and ensure compliance.
We examined the effect of the Medicare Part D coverage gap on drug costs and adherence among beneficiaries with diabetes in two large health systems offering MAPD plans.
Under health care reform, the Medicare Part D coverage gap will be phased out by 2020.
8 million people with Medicare have received discounts on brand-name drugs in the Medicare Part D coverage gap, also known as the "donut hole," between January and August of this year.
Seniors with sufficient prescription drug use to have reached the Medicare Part D coverage gap were the focus in this analysis of 114,766 patients, using time-trend analyses of dispensing data from three large pharmacy chains.
Verispan's de-identified patient data coupled with The Amundsen Group's expert analysis will provide the truest, most clear picture of how patients are faring with regard to the Medicare Part D coverage gap.
Full browser ?